DekaBank Deutsche Girozentrale - FIVE PRIME THERAPEUTICS INC ownership

FIVE PRIME THERAPEUTICS INC's ticker is FPRX and the CUSIP is 33830X104. A total of 129 filers reported holding FIVE PRIME THERAPEUTICS INC in Q4 2015. The put-call ratio across all filers is 8.29 and the average weighting 0.5%.

Quarter-by-quarter ownership
DekaBank Deutsche Girozentrale ownership history of FIVE PRIME THERAPEUTICS INC
ValueSharesWeighting
Q1 2021$486,000
+109.5%
13,0000.0%0.00%
+100.0%
Q4 2020$232,000
+68.1%
13,000
-43.0%
0.00%0.0%
Q2 2019$138,000
-96.6%
22,800
-92.0%
0.00%
-95.8%
Q1 2019$4,019,000
+4043.3%
284,200
+2393.0%
0.02%
+2300.0%
Q4 2018$97,000
-97.6%
11,400
-96.0%
0.00%
-95.8%
Q3 2018$4,019,000
+1718.6%
284,200
+1901.4%
0.02%
+2300.0%
Q2 2018$221,000
-95.0%
14,200
-94.8%
0.00%
-96.7%
Q1 2018$4,456,000
+19.8%
274,200
+110.1%
0.03%
+3.4%
Q4 2017$3,721,0000.0%130,5000.0%0.03%0.0%
Q3 2017$3,721,000
-9.6%
130,5000.0%0.03%
-12.1%
Q2 2017$4,116,000
+672.2%
130,500
+800.0%
0.03%
+560.0%
Q1 2017$533,000
-32.4%
14,500
-7.6%
0.01%
-37.5%
Q4 2016$788,000
+4.8%
15,700
+8.3%
0.01%0.0%
Q3 2016$752,000
+24.5%
14,5000.0%0.01%
+14.3%
Q2 2016$604,000
+28.5%
14,500
+22.9%
0.01%
+16.7%
Q1 2016$470,000
-13.8%
11,800
-9.9%
0.01%0.0%
Q4 2015$545,000
+173.9%
13,100
+1.6%
0.01%
+200.0%
Q3 2015$199,000
-34.3%
12,900
+5.7%
0.00%
-50.0%
Q2 2015$303,000
+13.5%
12,200
+4.3%
0.00%
+33.3%
Q1 2015$267,00011,7000.00%
Other shareholders
FIVE PRIME THERAPEUTICS INC shareholders Q4 2015
NameSharesValueWeighting ↓
BVF INC/IL 2,781,346$25,867,0003.38%
GREAT POINT PARTNERS LLC 2,398,409$22,305,0002.82%
Sofinnova Investments, Inc. 315,344$2,933,0000.36%
EcoR1 Capital, LLC 326,775$3,039,0000.30%
Rock Springs Capital Management LP 505,000$4,697,0000.22%
Hilltop Holdings Inc. 36,146$336,0000.08%
OXFORD ASSET MANAGEMENT LLP 285,237$2,653,0000.07%
PLATINUM INVESTMENT MANAGEMENT LTD 191,237$1,779,0000.06%
FOX RUN MANAGEMENT, L.L.C. 12,132$113,0000.06%
Virtus ETF Advisers LLC 31,427$292,0000.05%
View complete list of FIVE PRIME THERAPEUTICS INC shareholders